Spermatogenesis After Gonadotoxic Childhood Treatment: Follow-up of 12 Patients
Overview
Authors
Affiliations
Study Question: What is the long-term impact of presumed gonadotoxic treatment during childhood on the patient's testicular function at adulthood?
Summary Answer: Although most patients showed low testicular volumes and some degree of reproductive hormone disruption 12.3 (2.3-21.0) years after gonadotoxic childhood therapy, active spermatogenesis was demonstrated in the semen sample of 8 out of the 12 patients.
What Is Known Already: In recent decades, experimental testicular tissue banking programmes have been set up to safeguard the future fertility of young boys requiring chemo- and/or radiotherapy with significant gonadotoxicity. Although the risk of azoospermia following such therapies is estimated to be high, only limited long-term data are available on the reproductive potential at adulthood.
Study Design Size Duration: This single-centre prospective cohort study was conducted between September 2020 and February 2023 and involved 12 adult patients.
Participants/materials Setting Methods: This study was carried out in a tertiary care centre and included 12 young adults (18.1-28.3 years old) who had been offered testicular tissue banking prior to gonadotoxic treatment during childhood. All patients had a consultation and physical examination with a fertility specialist, a scrotal ultrasound to measure the testicular volumes and evaluate the testicular parenchyma, a blood test for assessment of reproductive hormones, and a semen analysis.
Main Results And The Role Of Chance: Testicular tissue was banked prior to the gonadotoxic treatment for 10 out of the 12 included patients. Testicular volumes were low for 9 patients, and 10 patients showed some degree of reproductive hormone disruption. Remarkably, ongoing spermatogenesis was demonstrated in 8 patients at a median 12.3 (range 2.3-21.0) years post-treatment.
Limitations Reasons For Caution: This study had a limited sample size, making additional research with a larger study population necessary to verify these preliminary findings.
Wider Implications Of The Findings: These findings highlight the need for multicentric research with a larger study population to establish universal inclusion criteria for immature testicular tissue banking.
Study Funding/competing Interests: This study was conducted with financial support from the Research Programme of the Research Foundation-Flanders (G010918N), Kom Op Tegen Kanker, and Scientific Fund Willy Gepts (WFWG19-03). The authors declare no competing interests.
Trial Registration Number: NCT04202094; https://clinicaltrials.gov/ct2/show/NCT04202094?id=NCT04202094&draw=2&rank=1 This study was registered on 6 December 2019, and the first patient was enrolled on 8 September 2020.
Duffin K, Neuhaus N, Andersen C, Barraud-Lange V, Braye A, Eguizabal C Hum Reprod Open. 2024; 2024(2):hoae010.
PMID: 38449521 PMC: 10914450. DOI: 10.1093/hropen/hoae010.
Endocrine disrupting chemicals and male fertility: from physiological to molecular effects.
Lahimer M, Abou Diwan M, Montjean D, Cabry R, Bach V, Ajina M Front Public Health. 2023; 11:1232646.
PMID: 37886048 PMC: 10598475. DOI: 10.3389/fpubh.2023.1232646.